ACH-LACOSAMIDE 50 MG
LACOSAMIDE : 50 MG · DIN 02489287 · ACCORD HEALTHCARE INC
Health Canada status: MARKETED
What is ACH-LACOSAMIDE?
ACH-LACOSAMIDE 50 MG contains LACOSAMIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02489287, held by ACCORD HEALTHCARE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 27-Apr-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ACH-LACOSAMIDE used for?
ACH-LACOSAMIDE (lacosamide) is indicated as monotherapy in the management of partial-onset seizures in adult (>18 years of age) patients with epilepsy. It is also indicated as adjunctive therapy in the management of partial-onset seizures in adult patients with epilepsy who are not satisfactorily controlled with conventional therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02489287 |
|---|---|
| Brand name | ACH-LACOSAMIDE |
| Generic / active ingredient | LACOSAMIDE : 50 MG |
| Manufacturer | ACCORD HEALTHCARE INC |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N03AX18 LACOSAMIDE |
| AHFS class | 28:12.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Apr-2021 |
| Original market date | 2021-04-27 00:00:00 |
How is it stored and handled?
null
How is it supplied?
50 mg tablet: HDPE bottles of 60, 180 and 1000, and as carton containing blister of 14 tablets. 100 mg tablet: HDPE bottles of 60, 180 and 1000 and as carton containing blister of 14 tablets. 150 mg tablet: HDPE bottles of 60, 180 and 1000 and as carton containing blister of 14 tablets. 200 mg tablet: HDPE bottles of 60, 180 and 1000 and as carton containing blister of 14 tablets.
What can be used instead?
Other Canadian products sharing ATC code N03AX18 LACOSAMIDE. 41 of 66 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-LACOSAMIDE | 100 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02489295 |
| ACH-LACOSAMIDE | 150 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02489309 |
| ACH-LACOSAMIDE | 200 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02489317 |
| AURO-LACOSAMIDE | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02475340 |
| AURO-LACOSAMIDE | 150 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02475359 |
| AURO-LACOSAMIDE | 200 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02475367 |
| AURO-LACOSAMIDE | 50 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02475332 |
| JAMP-LACOSAMIDE | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02488396 |
| JAMP-LACOSAMIDE | 150 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02488418 |
| JAMP-LACOSAMIDE | 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02488426 |
Who else supplies LACOSAMIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LACOSAMIDE appears in 1195 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.